Form 4: Gevo Director Sells Shares After Option Exercise

Gevo Director Angelo Amorelli exercised stock options and subsequently sold 100,000 shares of common stock for a weighted average price of $2.5027 per share, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Angelo Amorelli, a Director of Gevo, Inc. (GEVO), reported transactions involving the company's common stock.
• On October 14, 2025, Amorelli exercised 100,000 stock options at an exercise price of $0.67 per share.
• Concurrently, Amorelli sold 100,000 shares of Gevo common stock at a weighted average price of $2.5027 per share.
• The sale price ranged from $2.500 to $2.505 per share.
• These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Amorelli on December 3, 2024.
• Following these transactions, Amorelli directly beneficially owns 2,942 shares of common stock and 24,639 stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While a director selling shares can sometimes be viewed negatively, the transaction was pre-planned under a 10b5-1 plan, indicating it's a scheduled liquidity event rather than a reaction to new, material non-public information. The exercise of options also indicates the options were in-the-money, which is a positive for the director.

Positives

• The director profited significantly from the option exercise, acquiring shares at $0.67 and selling them at a weighted average of $2.5027, indicating the options were substantially in-the-money.

Negatives

• A director selling a substantial number of shares, even if planned, can sometimes be interpreted negatively by the market as a reduction in insider ownership.

Risks

• NA

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders might interpret the sale of a significant number of shares by a director as a reduction in insider confidence, although the execution under a 10b5-1 plan mitigates this concern by indicating a pre-scheduled transaction rather than a discretionary one based on immediate market views.

Next Steps

• NA

Key Dates

Recommendation

The filing details a planned insider sale by a director, which is a common occurrence for compensation and diversification. While a sale might be perceived negatively, the transaction was executed under a pre-arranged 10b5-1 trading plan, suggesting it's not based on new, material non-public information. Without further context on company performance or strategic shifts, this single transaction does not warrant a change from a 'hold' position.

Keywords

Gevo, GEVO, Form 4, insider transaction, stock option exercise, share sale, Angelo Amorelli, 10b5-1 plan